Ovarian germ cell tumor surgery: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
{| class="wikitable"
{| class="wikitable"
|+
|+
!
! colspan="2" |Management of Mature Teratoma
!
!
|-
|-
|Mature Teratoma
|Mature Teratoma
Line 29: Line 27:
**No plans for future [[pregnancy]]
**No plans for future [[pregnancy]]
**[[Menopausal|Post-menopausal]] women
**[[Menopausal|Post-menopausal]] women
|
|-
|-
!
! colspan="2" |Management of [[Dysgerminoma|Dysgerminomas]]<ref name="xxx" /><ref name="abc" /><ref name="aaa" /><ref name="ccc" />
!Management of [[Dysgerminoma|Dysgerminomas]]<ref name="xxx" /><ref name="abc" /><ref name="aaa" /><ref name="ccc" />
!Other tumors
|-
|-
|Stage I ovarian germ cell tumors
|Stage I ovarian germ cell tumors
Line 44: Line 39:
* Patients with [[Surgery|surgically]] staged stage IA [[tumors]] may be observed carefully after [[surgery]] without the need for [[adjuvant treatment]].
* Patients with [[Surgery|surgically]] staged stage IA [[tumors]] may be observed carefully after [[surgery]] without the need for [[adjuvant treatment]].
* Patients with incompletely staged [[tumor]] through [[surgery]] or those with higher stages may need [[adjuvant treatment]].
* Patients with incompletely staged [[tumor]] through [[surgery]] or those with higher stages may need [[adjuvant treatment]].
|
|-
|-
|Stage II ovarian germ cell tumors
|Stage II ovarian germ cell tumors
Line 53: Line 47:
** [[Radiotherapy]] has been associated with [[ovarian failure]].
** [[Radiotherapy]] has been associated with [[ovarian failure]].
** [[Adjuvant]] [[chemotherapy]] with the [[platinum]]-based regimen has replaced [[radiation therapy]] except in the rare patient in whom [[chemotherapy]] is not considered appropriate.
** [[Adjuvant]] [[chemotherapy]] with the [[platinum]]-based regimen has replaced [[radiation therapy]] except in the rare patient in whom [[chemotherapy]] is not considered appropriate.
|
|-
|-
|Stage III ovarian germ cell tumors
|Stage III ovarian germ cell tumors
Line 61: Line 54:
:** This strategy is not beneficial in patients with completely resected [[tumors]] who receive [[cisplatin]]-based [[adjuvant treatment]].
:** This strategy is not beneficial in patients with completely resected [[tumors]] who receive [[cisplatin]]-based [[adjuvant treatment]].
:** Second-look [[surgery]] may be beneficial in those whose [[tumor]] was not completely resected at the initial [[surgical]] procedure and who had teratomatous elements in their primary [[tumor]].
:** Second-look [[surgery]] may be beneficial in those whose [[tumor]] was not completely resected at the initial [[surgical]] procedure and who had teratomatous elements in their primary [[tumor]].
|
|-
|-
|Stage IV ovarian germ cell tumors
|Stage IV ovarian germ cell tumors
Line 68: Line 60:
:* Unilateral [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]]
:* Unilateral [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]]
:** [[Chemotherapy]] is the preferred treatment in the patient who wants to preserve [[fertility]].
:** [[Chemotherapy]] is the preferred treatment in the patient who wants to preserve [[fertility]].
|}
===Management options of Other Ovarian Tumors===
:*
{| class="wikitable"
|+
! colspan="2" |Surgical options for other ovarian tumors
|-
|Stage I ovarian germ cell tumors
|
* Unilateral [[salpingo-oophorectomy]] with [[adjuvant chemotherapy]]
* Unilateral [[salpingo-oophorectomy]] followed by [[observation]]
* Unilateral [[salpingo-oophorectomy]] with conservation of [[uterus]] and contralateral [[ovar]] is [[Indication (medicine)|indicated]] in those who plan for future [[pregnancies]].
* [[Chemotherapy agent|Chemotherapy]] is usually done postoperatively in those with [[ovarian]] [[germ cell]] [[tumors]] other than pure [[dysgerminoma]] and low grade (grade 1) immature [[teratoma]], but it can also preserved for those whose [[tumors]] [[relapse]] after the [[surgery]].
|-
|Stage II ovarian germ cell tumors
|
* Total [[abdominal]] [[hysterectomy]] and [[bilateral]] [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]], with or without [[neoadjuvant chemotherapy]]
* Unilateral [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]], with or without [[neoadjuvant chemotherapy]]
* Second-look [[laparotomy]]
|-
|Stage III ovarian germ cell tumors
|
|
* Total [[abdominal]] [[hysterectomy]] and [[bilateral]] [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]]
* Unilateral [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]]
|-
|Stage IV ovarian germ cell tumors
|
* Total [[abdominal]] [[hysterectomy]] and [[bilateral]] [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]] with or without [[neoadjuvant chemotherapy]]
* Unilateral [[salpingo-oophorectomy]] with [[adjuvant]] [[chemotherapy]] with or without [[neoadjuvant chemotherapy]]
|}
|}
===Mature teratoma===
**
===Management of ===
* [[Surgery]] is the mainstay of treatment in [[Dysgerminoma|dysgerminomas]].
* Depending upon the staging and severity adjuavant Additional [[chemotherapy]] and/or [[radiotherapy]] depend on the [[stage]] of the [[tumor]].<ref name="VicusBeiner2010">{{cite journal|last1=Vicus|first1=Danielle|last2=Beiner|first2=Mario E.|last3=Klachook|first3=Shany|last4=Le|first4=Lisa W.|last5=Laframboise|first5=Stephane|last6=Mackay|first6=Helen|title=Pure dysgerminoma of the ovary 35 years on: A single institutional experience|journal=Gynecologic Oncology|volume=117|issue=1|year=2010|pages=23–26|issn=00908258|doi=10.1016/j.ygyno.2009.12.024}}</ref>
* Stage 1A: [[fertility]]-preserving [[surgery]] without [[adjuvant]] [[chemotherapy]] or [[radiotherapy]].<ref name="AL HusainiSoudy2012">{{cite journal|last1=AL Husaini|first1=Hamed|last2=Soudy|first2=Hussein|last3=Darwish|first3=Alaa El Din|last4=Ahmed|first4=Mohamed|last5=Eltigani|first5=Amin|last6=AL Mubarak|first6=Mustafa|last7=Sabaa|first7=Amal Abu|last8=Edesa|first8=Wael|last9=AL-Tweigeri|first9=Taher|last10=Al-Badawi|first10=Ismail A.|title=Pure dysgerminoma of the ovary: a single institutional experience of 65 patients|journal=Medical Oncology|volume=29|issue=4|year=2012|pages=2944–2948|issn=1357-0560|doi=10.1007/s12032-012-0194-z}}</ref>
**
* Other [[germ cell]] [[tumors]]
:* Unilateral [[salpingo-oophorectomy]] with [[adjuvant chemotherapy]]
:* Unilateral [[salpingo-oophorectomy]] with [[adjuvant chemotherapy]]
:* Unilateral [[salpingo-oophorectomy]] followed by [[observation]]
:* Unilateral [[salpingo-oophorectomy]] followed by [[observation]]

Revision as of 23:57, 10 April 2019

Ovarian germ cell tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Ovarian germ cell tumor from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Chemotherapy

Radiotherapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ovarian germ cell tumor surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ovarian germ cell tumor surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ovarian germ cell tumor surgery

CDC on Ovarian germ cell tumor surgery

Ovarian germ cell tumor surgery in the news

Blogs on Ovarian germ cell tumor surgery

Directions to Hospitals Treating Ovarian germ cell tumor

Risk calculators and risk factors for Ovarian germ cell tumor surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Surgical intervention is the mainstay of management of ovarian germ cell tumors. Surgery is recommended both for staging and choosing appropriate treatment approaches. accordingly. Surgical management of the ovarian germ cell tumors, for the purpose of treatment, classified to two categories according to the preference of the patient to preserve the ovary or not.

Surgery

Management of Mature Teratoma
Mature Teratoma
Management of Dysgerminomas[1][2][3][4]
Stage I ovarian germ cell tumors
Stage II ovarian germ cell tumors
Stage III ovarian germ cell tumors
Stage IV ovarian germ cell tumors

Management options of Other Ovarian Tumors

Surgical options for other ovarian tumors
Stage I ovarian germ cell tumors
Stage II ovarian germ cell tumors
Stage III ovarian germ cell tumors
Stage IV ovarian germ cell tumors

References

  1. 1.0 1.1 1.2 1.3 Stage I Ovarian Germ Cell Tumors . http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_33. URL Accessed on Nov 5, 2015
  2. 2.0 2.1 2.2 2.3 Stage II Ovarian Germ Cell Tumors . http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_43. URL Accessed on Nov 5, 2015
  3. 3.0 3.1 3.2 3.3 Stage III Ovarian Germ Cell Tumors . http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_54. URL Accessed on Nov 5, 2015
  4. 4.0 4.1 4.2 4.3 Stage IV Ovarian Germ Cell Tumors . http://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq#section/_65. URL Accessed on Nov 5, 2015
  5. Gershenson, David M. (2007). "Management of Ovarian Germ Cell Tumors". Journal of Clinical Oncology. 25 (20): 2938–2943. doi:10.1200/JCO.2007.10.8738. ISSN 0732-183X.
  6. Yayla Abide, Çiğdem; Bostancı Ergen, Evrim (2018). "Retrospective analysis of mature cystic teratomas in a single center and review of the literature". Journal of Turkish Society of Obstetric and Gynecology. 15 (2): 95–98. doi:10.4274/tjod.86244. ISSN 1307-699X.
  7. 7.0 7.1 Caspi, Benjamin; Appelman, Zvi; Rabinerson, David; Zalel, Yaron; Tulandi, Togas; Shoham, Zeev (1997). "The growth pattern of ovarian dermoid cysts: a prospective study in premenopausal and postmenopausal women". Fertility and Sterility. 68 (3): 501–505. doi:10.1016/S0015-0282(97)00228-8. ISSN 0015-0282.

Template:WikiDoc Sources [[Category:Surgery]